Richard Heywood, DO
Obstetrics & Gynecology · Mashpee, MANPI 1336118066
Payments from drug & device makers
Across 39 payments — averaging $50.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$802
- Hologic Sales And Service, LLC$237
- Cytyc Surgical Products, LLC$175
- Mayne Pharma Commercial LLC$136
- Astellas Pharma US Inc$123
- AbbVie$112
- plus $367 from 11 others
What the payments were for
- Consulting fees$35018%
- Travel & lodging$56829%
- Food & beverage$93348%
- Education$1005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $802 |
| Hologic Sales And Service, LLC | 3 | $237 |
| Cytyc Surgical Products, LLC | 1 | $175 |
| Mayne Pharma Commercial LLC | 2 | $136 |
| Astellas Pharma US Inc | 2 | $123 |
| AbbVie | 2 | $112 |
| Coopersurgical, Inc. | 2 | $58 |
| Exeltis, USA Inc. | 2 | $57 |
| Merck | 3 | $57 |
| Organon | 2 | $35 |
| Bayer | 2 | $31 |
| Myovant Sciences Inc. | 1 | $29 |
| Aspira Women's Health Inc | 1 | $27 |
| Johnson & Johnson | 1 | $24 |
| Amgen | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Teleflex LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADVANTAGE$465
- NEXTSTELLIS$114
How this compares
$1,951 in reported general payments places this provider in the 85th percentile of 910 obstetrics & gynecology providers in Massachusetts.
See all obstetrics & gynecology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 80 | $4,566 |
| Estradiol (Twice Weekly)Estradiol | 19 | $2,187 |
| Estradiol (Once Weekly)Estradiol | 12 | $1,434 |
| ValacyclovirValacyclovir Hcl | 25 | $1,163 |
| Clobetasol Propionate | 19 | $1,117 |
| Alendronate Sodium | 13 | $132 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Mashpee
- Alyssa KratochvilFall River$1.9M
- Soheil Amin HanjaniBrockton$395K
- Alisa GoldbergBoston$341K
- Caroline MitchellBoston$293K
- Andrea EdlowBoston$273K
- Joelle LiemanBrighton$215K
- Michelle LightfootBoston$168K
- Katharine WhiteBoston$162K
- Elizabeth OnyemelukweBoston$135K
- James GreenbergBoston$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.